A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists.
Burkholderia pseudomallei causes the disease melioidosis in humans and is classified as a category B select agent. Research utilizing this pathogen is highly regulated in the United States, and even basic studies must be conducted in biosafety level 3 (BSL-3) facilities. There is currently no attenuated B. pseudomallei strain available that is excluded from select-agent regulations and can be safely handled at BSL-2 facilities. To address this need, we created Bp82 and Bp190, which are DeltapurM derivatives of B. pseudomallei strains 1026b and K96243 that are deficient in adenine and thiamine biosynthesis but replication competent in vitro in rich medium. A series of animal challenge studies was conducted to ensure that these strains were fully attenuated. Whereas the parental strains 1026b and K96243 and the complemented mutants Bp410 and Bp454 were virulent in BALB/c mice following intranasal inoculation, the DeltapurM mutants Bp82 and Bp190 were avirulent even when they were administered at doses 4 logs higher than the doses used for the parental strains. Animals challenged with high doses of the DeltapurM mutants rapidly cleared the bacterium from tissues (lung, liver, and spleen) and remained free of culturable bacteria for the duration of the experiments (up to 60 days postinfection). Moreover, highly susceptible 129/SvEv mice and immune incompetent mice (IFN-gamma-/-, SCID) were resistant to challenges with DeltapurM mutant Bp82. This strain was also avirulent in the Syrian hamster challenge model. We concluded that DeltapurM mutant Bp82 is fully attenuated and safe for use under BSL-2 laboratory conditions and thus is a candidate for exclusion from the select-agent list.
Propst
Katie L
KL
Department of Microbiology, Immunology and Pathology, Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, Colorado State University, Fort Collins, Colorado 80523-2025, USA.
Mima
Takehiko
T
Choi
Kyoung-Hee
KH
Dow
Steven W
SW
Schweizer
Herbert P
HP
D000818:Animals; D016957:Burkholderia pseudomallei / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D006224:Cricetinae; D005260:Female; D017353:Gene Deletion; D005798:Genes, Bacterial / Q000235:genetics / Q000502:physiology; D008099:Liver / Q000276:immunology / Q000382:microbiology; D008168:Lung / Q000276:immunology / Q000382:microbiology; D008554:Melioidosis / Q000276:immunology / Q000382:microbiology*; D008647:Mesocricetus; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D016296:Mutagenesis / Q000235:genetics; D013154:Spleen / Q000276:immunology / Q000382:microbiology
Infect Immun. 2006 Sep;74(9):5333-40
16926428
Infect Immun. 2005 Feb;73(2):1106-15
15664954
Emerg Infect Dis. 2005 Oct;11(10):1638-9
16355505
Appl Environ Microbiol. 2008 Feb;74(4):1064-75
18156318
Nat Rev Microbiol. 2006 Apr;4(4):272-82
16541135
MMWR Morb Mortal Wkly Rep. 2006 Aug 18;55(32):873-6
16915220
Infect Immun. 2009 Apr;77(4):1579-88
19179415
Infect Immun. 2005 Feb;73(2):1260-4
15664977
Infect Immun. 1999 Jul;67(7):3593-600
10377144
Emerg Infect Dis. 2008 Jul;14(7):e2
18598617
J Immunol. 2010 Feb 1;184(3):1445-54
20042590
Infect Immun. 1999 Jun;67(6):2867-73
10338493
Microbiology (Reading). 2004 Aug;150(Pt 8):2669-2676
15289563
Appl Environ Microbiol. 2008 May;74(10):2985-9
18310423
J Bacteriol. 1997 Apr;179(7):2116-25
9079894
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14240-5
15377794
Infect Immun. 2003 Dec;71(12):7002-13
14638790
Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S89-94
19121696
Clin Infect Dis. 2006 Oct 15;43(8):979-86
16983608
J Med Microbiol. 2002 Jul;51(7):539-553
12132769
N Engl J Med. 1981 Nov 5;305(19):1133-5
7290119
PLoS One. 2008 Apr 30;3(4):e2058
18446194
Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):123-30
19323044
Expert Rev Anti Infect Ther. 2006 Jun;4(3):445-55
16771621
Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S1-4
19121666
Scand J Infect Dis. 2006;38(1):71-4
16338844
Clin Microbiol Rev. 2005 Apr;18(2):383-416
15831829
Infect Immun. 2003 Jul;71(7):3960-70
12819083
Infect Immun. 2004 Aug;72(8):4911-7
15271960
Clin Infect Dis. 2005 Oct 1;41(7):982-90
16142663
Infect Immun. 2006 Aug;74(8):4452-61
16861631
Infect Immun. 2001 Jan;69(1):34-44
11119486
Appl Environ Microbiol. 2009 Oct;75(20):6496-503
19700544
Infect Immun. 2002 Sep;70(9):5290-4
12183585
Infect Immun. 2006 Jun;74(6):3576-86
16714590
Infect Immun. 2006 Oct;74(10):5465-76
16988221
Emerg Infect Dis. 2008 Nov;14(11):1689-92
18976550
J Chemother. 2006 Aug;18(4):443-4
17024805
Eur Respir J. 2003 Sep;22(3):542-50
14516149